Related Experiment Video
Updated: Dec 22, 2025
03:50
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
Published on: August 2, 2024
1.8K
[Extracorporeal shock wave therapy for Peyronie's disease]
A Ochoa1, C Guillot-Tantay1, A Faix2
1Sorbonne Université, GRC 5 Predictive Onco-Uro, AP-HP, Urologie, Pitie-Salpétrière, 75013 Paris, France.
Summary
Extracorporeal shock wave therapy (SWT) may help manage pain in Peyronie
Area of Science:
- Urology
- Andrology
- Regenerative Medicine
Background:
- Peyronie's disease (PD) is a condition affecting penile health.
- The efficacy of extracorporeal shock wave therapy (SWT) for PD remains debated.
Purpose of the Study:
- To systematically review the literature on SWT for Peyronie's disease.
- To evaluate the effectiveness of SWT on pain, plaque size, and penile curvature in PD patients.
Main Methods:
- Systematic literature review (2000-2019) using PRISMA methodology.
- Analysis of Medline database for relevant studies on SWT and PD.
- Inclusion of 13 selected articles.
Main Results:
- SWT demonstrated benefits in alleviating pain associated with Peyronie's disease.
- Results regarding the impact of SWT on plaque size and penile curvature were inconsistent.
- Divergent outcomes were observed across studies evaluating plaque characteristics and penile deformity.
Conclusions:
- SWT may be a valuable adjunct for pain management in select PD patients.
- Further high-quality, randomized controlled trials are necessary to confirm efficacy for plaque size and curvature.
- Standardization of treatment protocols and patient selection is crucial for future research.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
433
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
433
01:30Electroconvulsive Therapy
621
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
621
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
372
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
372
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
351
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
351
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
190
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
190